{
  "pmcid": "10804009",
  "sha256": "a512c622b8f7648c84b539f51a19906830113dfd87693b61763eb8dd9e50bb36",
  "timestamp_utc": "2025-11-09T23:09:45.098886+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.713247535596935,
    "reading_ease": 31.243430996714153,
    "word_count": 249
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Drug-Eluting Balloon Angioplasty in Preventing In-Stent Restenosis in Postirradiated Carotid Stenosis"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Sixty-six patients with severe PIRCS were randomly assigned to DEB-PTAS (n=30) or conventional PTAS (n=36) based on the last digit of their chart number."
      },
      "Participants": {
        "score": 2,
        "evidence": "Sixty-six patients with severe PIRCS were randomly assigned... This open-label, randomised controlled trial was conducted at a single hospital from July 2017 to July 2021."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Sixty-six patients with severe PIRCS were randomly assigned to DEB-PTAS (n=30) or conventional PTAS (n=36)."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates the efficacy and safety of drug-eluting balloon (DEB) angioplasty in preventing ISR in PIRCS."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the degree of ISR at 12 months, assessed by CT/MR angiography."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Sixty-six patients with severe PIRCS were randomly assigned... based on the last digit of their chart number."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Randomisation was not concealed, and blinding was not applied."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Sixty-six patients with severe PIRCS were randomly assigned to DEB-PTAS (n=30) or conventional PTAS (n=36)... from July 2017 to July 2021."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Sixty-five patients were analysed (DEB: 29, conventional: 36)."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The DEB group demonstrated significantly lower ISR (26.58±8.75% vs 45.93±20.86%; P<0.001) and fewer cases of significant ISR (≥50%) (3.4% vs 38.9%; P=0.029)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were similar between groups."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Not disclosed."
      }
    },
    "total_score": 18,
    "max_score": 25
  }
}